Stages of formation and main achievements of the Chemotherapy Department of Kazakh Research Institute of Oncology and Radiology

Dilyara Kaidarova, N. Chichua, Kaldygul Kabakovna Smagulova, Suriya Yessentayeva, Aliya Turesheva, Р. Абдрахманов

2020

Closed access Metadata (CSL-JSON)
DOI 10.52532/2521-6414-2020-4-58-107-114
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

The article talks about the Chemotherapy Department of the Kazakh Research Institute of Oncology and Radiology (KazIOR), which is an important part of cancer patients’ treatment in the Republic of Kazakhstan. The roll-out of clinical chemotherapy as one of the main cancer treatment methods was initiated by Professor S.N. Nugmanov, the director of KazIOR, in 1963, three years after the Institute was established. In addition to clinical activities, the department staff conducts research, participates in clinical trials, provides consulting and methodological assistance in consolidating the national chemotherapy service, and develops national clinical cancer treatment guidelines.